1. Yang, Linlin, Zerbato, Barbara, Pessina, Alex, Du, Xin, Grimbacher, Bodo. 2024. PGM3 insufficiency: a glycosylation disorder causing a notable T cell defect. In Frontiers in immunology, 15, 1500381. doi:10.3389/fimmu.2024.1500381. https://pubmed.ncbi.nlm.nih.gov/39776909/
2. Walther, Thomas, Baylac, Audrey, Alkim, Ceren, Cordier, Hélène, François, Jean Marie. 2012. The PGM3 gene encodes the major phosphoribomutase in the yeast Saccharomyces cerevisiae. In FEBS letters, 586, 4114-8. doi:10.1016/j.febslet.2012.09.042. https://pubmed.ncbi.nlm.nih.gov/23103740/
3. Elhossini, Rasha Moheb, Ahmed, Hoda Abdalla, Otaify, Ghada, Amr, Khalda, Aglan, Mona. 2022. A novel variant in GNPNAT1 gene causing a spondylo-epi-metaphyseal dysplasia resembling PGM3-Desbuquois like dysplasia. In American journal of medical genetics. Part A, 188, 2861-2868. doi:10.1002/ajmg.a.62933. https://pubmed.ncbi.nlm.nih.gov/36097642/
4. Zhang, Nan, Liu, Si, Xu, Junxuan, Zhang, Shutian, Zhu, Shengtao. 2022. PGM3 regulates beta-catenin activity to promote colorectal cancer cell progression. In Experimental biology and medicine (Maywood, N.J.), 247, 1518-1528. doi:10.1177/15353702221101810. https://pubmed.ncbi.nlm.nih.gov/35723049/
5. Liu, Xiao-Rong, Bian, Wen-Jun, Wang, Jie, Yi, Yong-Hong, Liao, Wei-Ping. 2020. Heterozygous PGM3 Variants Are Associated With Idiopathic Focal Epilepsy With Incomplete Penetrance. In Frontiers in genetics, 11, 559080. doi:10.3389/fgene.2020.559080. https://pubmed.ncbi.nlm.nih.gov/33193641/